Following the initial trials in Africa of the groundbreaking drug that could put an end to AIDS

Precious closes her eyes and clenches her fists as the syringe needle penetrates her right thigh, slowly injecting a greenish-yellow liquid. The same procedure is repeated in her left thigh. “You’re protected for six months now!” the nurse exclaims. On that sunny March morning, in a small health center in Lobamba, a rural area of ​​Eswatini, this 32-year-old sex worker has just become one of the first people in the world to receive lenacapavir, a drug that, administered twice a year, offers nearly 100% protection against HIV.

Seguir leyendo